Brief: Ekso Bionics Announces $3.7 Million Registered Direct Offering Of Common Stock Priced At-The-Market Under Nasdaq Rules
29/10/2025 12:55
Ekso Bionics Holdings Inc EKSO.O: EKSO BIONICS ANNOUNCES $3.7 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES Source text: ID:nGNX2G4XHK Further company coverage: EKSO.O
Recent news on Chronoscale
See all newsBrief: Soluna To Form Strategic Partnership With Applied Digital For Wind-Powered AI Data Center In Texas
Brief: Chronoscale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue To $1 Billion And Sale Of Ekso Bionics Business Unit
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
U.S. STOCKS ON THE MOVE-Veeva Systems, Dollar General, ChronoScale